An Endometrial Cancer Chemoprevention Study of Metformin versus No Treatment in Women with a Body Mass Index (BMI) >/= 35 kg.m2 and hyperinsulinemia

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Jun 2019 Biomarkers information updated
04 May 2013 New source identified and integrated (M.D. Anderson Cancer Center; 2011-0739).
03 May 2013 Planned end date changed from 1 Jul 2019 to 1 May 2019 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com